Efficacy of medication directed by home-monitoring cardiac resynchronization therapy in chronic heart failure patients.
- Author:
Hao YANG
1
;
Fei-fei ZHANG
1
;
Xin-hui PENG
1
;
Dong-hua ZHAO
1
;
Jian PENG
1
Author Information
1. Department of Cardiology, Nanfang Hospital, Southern Medical University,Guangzhou 510515, China.
- Publication Type:Clinical Trial
- MeSH:
Cardiac Resynchronization Therapy;
methods;
Cardiac Resynchronization Therapy Devices;
Chronic Disease;
Heart Failure;
drug therapy;
Heart Function Tests;
Humans;
Remote Sensing Technology;
instrumentation;
methods;
Treatment Outcome
- From:
Chinese Medical Sciences Journal
2014;29(1):61-62
- CountryChina
- Language:English
-
Abstract:
PATIENTS with chronic heart failure (CHF) have a high incidence of atrial/ventricular arrhythmias which seriously affect life span and quality of life. Cardiac re-synchronization therapy (CRT) can improve cardiac function and reverse myocardial remodeling, therefore improving the quality of life and reducing mortality. CRT with Home-Monitoring (HM) can be used to monitor cardiac arrhythmias and other heart physiological indexes such as intrathoracic impedance and hemodynamics. Through wireless satellites, the data from the patients are sent to a monitor center for analysis. Doctors can identify emergent information and make a rapid diagnosis based on the information stored in the monitor center. CRT with HM has been verified as a valid method to optimize drug treatment according to individual parameters.
